This paper is intended to identify both barriers to AI deployment at scale in developing countries and the types of regulatory and public policy actions that can best accelerate the appropriate use of AI to improve healthcare in developing countries’ contexts.
This article seeks to inform the potential of bioprinting (3D printing of human organs), the legal aspects of the technology, its patentability, regulation, and ethical considerations. Although these patents are presumed valid, the validity of some of these might be litigated in due course, as the technology advances and the market expands.
This white paper attempts to lay out central concepts related to AI and complementary technologies, their rapid progress, and discuss the attendant salient legal, ethical, innovation and development policy issues. The paper aims at providing a broad overview of key issues thus stimulating World Bank Group wide discussion on the topic.